Understanding
ADHD &
QbCheck Testing
ADHD is a real, neurobiological condition — and one of the most treatable in psychiatry. MedStart Psychiatry is a 100% telehealth practice. We deliver expert ADHD evaluation and FDA-cleared QbCheck testing from the comfort of your home.
A Neurodevelopmental Condition,
Not a Lack of Willpower
ADHD is a chronic, neurobiological disorder involving differences in brain structure, function, and chemistry — particularly in dopamine and norepinephrine systems governing attention, impulse control, and executive function. It affects 3–7% of school-aged children and around 4.5% of adults worldwide.
Neuroimaging consistently shows differences in prefrontal cortex volume and connectivity in ADHD. Heritability is 70–80% — among the highest of any psychiatric condition — with hundreds of genetic variants identified through genome-wide association studies (Demontis et al., 2023). ADHD is not a choice or a character flaw.
DSM-5 requires several symptoms present before age 12. While hyperactivity often diminishes with age, inattentive symptoms and executive dysfunction frequently persist into adulthood — with many individuals receiving their first diagnosis at 30, 40, or even 50.
ADHD is diagnosed 2–3× more often in males, yet females are significantly underdiagnosed. Girls more commonly present with inattentive symptoms that are less disruptive — leading to delayed identification with serious consequences for mental health outcomes (Quinn & Madhoo, 2014).
Untreated ADHD is linked to lower educational and occupational attainment, relationship difficulties, elevated rates of anxiety, depression, and substance use, and higher risk of accidents. Adults may develop masking strategies that come at great personal cost. Early, accurate diagnosis transforms long-term outcomes (Barkley, 2015).
Three Distinct Presentations
The DSM-5 recognizes three presentations. Presentations can shift across the lifespan — a combined-type child may present predominantly inattentive in adulthood as overt hyperactivity subsides.
Difficulty sustaining focus, following instructions, and organizing tasks — without prominent hyperactivity. Frequently misidentified as laziness or anxiety, particularly in girls and adult women.
Excess motor activity, restlessness, and acting before thinking. In adults this typically manifests as inner restlessness, impatience, and impulsive decision-making rather than visible hyperactivity.
The most frequently diagnosed presentation — meeting criteria for both inattention and hyperactivity-impulsivity. Most children with ADHD fall here, experiencing impairment across all functional domains.
Recognizing ADHD Symptoms
What Is QbCheck?
QbCheck is an FDA-cleared, CE-marked computerized test developed by Qbtech that provides objective, quantified data to support ADHD assessment — cleared for ages 6–60 for both diagnostic aid and treatment monitoring. At MedStart, you complete QbCheck from home.
Objective Data for a Clearer Diagnosis
Traditional ADHD assessment relies on self-report, rating scales, and clinical interview — all subject to recall bias and subjective interpretation. It can be genuinely difficult to describe how ADHD feels from the inside. QbCheck adds an objective, measurable layer by directly capturing three core ADHD domains during a standardized, nonverbal computer task.
Developed by Qbtech (founded 2002) and validated in over 40 independent studies, QbCheck is used by more than 10,000 clinicians worldwide — including the NHS across 240+ sites in England. In 2025, Qbtech received the HSJ Digital Award for Improving Mental Health Through Digital.
Preparing for Your At-Home QbCheck
MedStart Psychiatry is a 100% telehealth practice. Your QbCheck is completed from the comfort of your own home using your laptop — no office visit needed. A little preparation ensures your results accurately reflect your baseline.
Common Questions About QbCheck
ADHD Rarely Travels Alone
60–80% of individuals with ADHD have at least one comorbid condition. Our evaluation systematically screens for these — because treating ADHD in isolation frequently leaves a significant part of the clinical picture unaddressed.
The most common adult comorbidity. Chronic underperformance and the unpredictability of ADHD frequently generate secondary anxiety that requires independent treatment alongside ADHD management.
Major Depression and Dysthymia occur at elevated rates across all ages in ADHD. Chronic failure experiences and neurobiological overlap both contribute significantly to this co-occurrence.
Dyslexia and dyscalculia co-occur frequently with ADHD. Academic underachievement may reflect both conditions, each requiring separate assessment and targeted educational support.
Common in children with ADHD, typically driven by frustration and emotional dysregulation. Effective ADHD treatment frequently reduces ODD symptoms significantly.
Delayed sleep phase, insomnia, and restless sleep are strongly linked to ADHD. Poor sleep amplifies inattention and emotional dysregulation — making sleep evaluation essential in every assessment.
Adults with untreated ADHD show higher rates of substance use, often representing self-medication. Effective ADHD treatment significantly reduces this risk over time (Wilens et al., 2008).
Personalized, Multimodal Care
Evidence strongly supports a multimodal approach to ADHD management. Treatment is individualized based on age, presentation, comorbidities, and patient preference — guided by current APA and AAP clinical guidelines.
First-line pharmacological treatment for ages 6+. Stimulants increase dopamine and norepinephrine availability in the prefrontal cortex, improving attention, impulse control, and executive function. Effect sizes of 0.8–1.0 make them among the most effective medications in all of psychiatry.
- Methylphenidate (Ritalin, Concerta, Focalin) — IR & ER formulations
- Amphetamine salts (Adderall, Vyvanse, Dexedrine) — IR & ER formulations
- Lisdexamfetamine (Vyvanse) — prodrug with lower misuse potential
- Individualized titration; QbCheck used to objectively measure treatment response
Effective alternatives when stimulants are contraindicated, not tolerated, or insufficient — particularly useful when co-occurring anxiety, tics, substance use history, or cardiovascular concerns are present.
- Atomoxetine (Strattera) — norepinephrine reuptake inhibitor; FDA-approved all ages
- Viloxazine (Qelbree) — newer SNRI; approved for children & adolescents
- Guanfacine ER (Intuniv) — helpful for hyperactivity & emotional dysregulation
- Clonidine ER (Kapvay) — used adjunctively for sleep difficulties and tics
- Bupropion — off-label use with evidence in adult ADHD
For children under 6, behavioral therapy is the recommended first-line treatment before medication. For older children and adults, therapy combined with medication produces the best outcomes — building lasting compensatory skills for daily functioning.
- Behavioral Parent Training (BPT) — first-line for preschoolers; highest evidence base
- Cognitive Behavioral Therapy (CBT) — addresses ADHD-specific thinking patterns and organization
- ADHD Coaching — practical skill-building for time management and follow-through
- Organizational Skills Training — structured school and work performance interventions
- Mindfulness-Based Cognitive Therapy (MBCT) — emerging evidence for adult ADHD
Evidence-based lifestyle modifications meaningfully augment pharmacological and psychological treatment — and are discussed with every patient as part of a comprehensive, individualized care plan.
- Aerobic exercise (30 min/day) — demonstrated attention improvements comparable to low-dose stimulants
- Sleep optimization — consistent schedule critical; comorbid sleep disorders treated independently
- Omega-3 supplementation — modest evidence as a safe, well-tolerated adjunct
- Structured routines and external scaffolding — reduce demands on impaired executive function
- School/workplace accommodations — 504 plans, extended time, reduced-distraction environments
- Digital tools for reminders, time-boxing, task management, and habit building
The MedStart Telehealth Process
Our comprehensive ADHD evaluation is thorough, evidence-based, and 100% from home — designed to give you clarity, confidence, and a clear path forward without leaving your house.
Schedule your telehealth appointment online in minutes. Complete pre-visit symptom questionnaires digitally before your video call.
A thorough video consultation covering symptom history, developmental background, family history, and comorbidity screening.
Complete the 15–20 min QbCheck on your laptop at home. Your webcam tracks movement while you complete the attention task.
Your psychiatrist integrates QbCheck data, rating scales, and clinical findings for a clear, evidence-based diagnosis via telehealth.
A tailored, multimodal plan — with prescriptions sent to your pharmacy and ongoing telehealth follow-up appointments.
Care That Goes Beyond the Checklist
Every appointment — consultation, QbCheck testing, results review, and follow-up — is completed from the comfort of your home. No commute, no waiting room, no office visit required.
We use FDA-cleared QbCheck in every ADHD evaluation — providing objective data that strengthens diagnostic accuracy and tracks your treatment progress over time with the same objective measure.
Advanced training in neurodevelopmental disorders across the lifespan — with particular experience in late-diagnosed adults, women, and complex presentations with multiple comorbidities.
We screen for anxiety, mood, sleep, and learning disorders alongside ADHD — because 60–80% of patients have significant comorbidities that must be addressed for full, lasting recovery.
Every recommendation is grounded in current clinical guidelines from the APA, AAP, AACAP, and NICE — with regular review of emerging research to keep our practice at the forefront of the field.
We coordinate closely with therapists, schools, and primary care providers — supplying accommodation letters, shared care plans, and referrals to build your complete support network.
Get Expert ADHD Care From Home
MedStart Psychiatry is a 100% telehealth practice. Your comprehensive ADHD evaluation — including objective QbCheck testing — is done entirely from home. No commute. No waiting room. Just expert care.
Book Your Assessment →100% Telehealth · Ages 6–60 · All appointments from home
Begin care with clarity and intention
Whether you are navigating something new or looking for more thoughtful long-term support, MedStart Psychiatry offers a personalized approach designed around you — not the diagnosis alone.
Insurance: We currently accept Tricare West. Additional plans are coming soon. Cash-pay patients are welcome — a superbill can be provided for potential out-of-network reimbursement.
New patients welcome · Appointments often available within 1–3 days · Telehealth · Arizona
Ready to take the next step?
New patients welcome. Appointments often available within 1–3 days. Accepting Tricare West — additional insurance coming soon.
Insurance: Tricare West accepted · Cash-pay & superbill available